###begin article-title 0
Epithelial IgG and its relationship to the loss of F508 in the common mutant form of the cystic fibrosis transmembrane conductance regulator
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
The most debilitating feature of cystic fibrosis (CF) disease is uncontrolled inflammation of respiratory epithelium. The relationship between the commonest mutated form of CFTR (F508del or DeltaF508) and inflammation has not yet been elucidated. Here, we present a new paradigm suggesting that CFTR can interact with intra-epithelial IgG, establishing a direct link between normal CFTR and the immune system. Further, our data show that the amino-acid sequence local to F508 can bind IgG with high affinity, dependent on F508, such that loss of F508 abolishes this link both in vitro and in the intact cell.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 255 260 251 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1 bib2" ref-type="bibr">[1,2]</xref>
###xml 394 397 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">[3]</xref>
###xml 643 646 635 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">[4]</xref>
###xml 919 922 911 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">[5]</xref>
###xml 1170 1173 1162 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr">[6]</xref>
###xml 1252 1255 1240 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr">[7]</xref>
###xml 1315 1318 1303 1306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">[8]</xref>
###xml 627 642 <span type="species:ncbi:10090">transgenic mice</span>
###xml 993 1001 <span type="species:ncbi:9606">patients</span>
Most cystic fibrosis (CF) arises from a single amino-acid deletion (DeltaF508) in the cystic fibrosis transmembrane conductance regulator (CFTR, ABCC7). The resulting multi-system disease has many unexplained features including disordered innate immunity [1,2]. F508 is in the first nucleotide-binding domain (NBD1) of CFTR but no significant structural alterations correlate with its deletion [3]. Since the F508 region forms an accessible loop, we speculated that this region might participate in protein-protein interactions. We therefore looked for candidate proteins in tracheal epithelium from DeltaF508CFTR or CFTR-null transgenic mice [4]. During our control immunohistochemical studies of tracheae, we noticed differential staining in the 'non-specific' background when secondary anti-IgG antibodies were applied in the absence of primary. This differential distribution segregated as expected for CFTR itself [5], suggesting that a CFTR-induced antibody-binding site was present. CF patients are mucosally infected with a restricted set of pathogens (see discussion) and some authors believe CF epithelia are spontaneously inflamed in the absence of infection [6]. CF cells secrete IL-8 in excess over wild-type due to activation of NFkappaB [7] and IgG levels are abnormally elevated in the CF gut lumen [8]. The serendipitous data presented here suggest that IgG binds to the F508 region of CFTR, F508-dependently.
###end p 6
###begin title 7
Materials and methods
###end title 7
###begin title 8
Immunohistochemistry
###end title 8
###begin p 9
###xml 153 156 149 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr">[9]</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Wax-embedded tracheal sections from wild-type, CFTR-null or homozygous DeltaF508 CF mice were mounted on glass slides and stained using diaminobenzidine [9]. HRP-labelled Protein-G (1 mug/ml; Sigma P8170) was used to stain tissue for endogenous IgG.
###end p 9
###begin title 10
Dotblots
###end title 10
###begin p 11
###xml 555 558 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 639 643 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr">[10]</xref>
###xml 578 583 <span type="species:ncbi:10090">mouse</span>
Peptides (10 nmol/dot) (KENIIFGVSYDEYRYRS (wild-type CFTR peptide 503-519), KENIIGVSYDEYRYRS (DeltaF508 CFTR peptide 503-518); SZ, GQNIHRKTTASTRK (CFTR 780-793); KE, KEHYVDLKDRPFFA (NDPK-A 49-62); GE, GETNPADSKPGTIR (NDPK-A 92-105)) were immobilised on nitrocellulose membranes using a Whatman-Biometra Hybrislot suction manifold. Membranes were blocked using 1% BSA then incubated with 1:1000 dilutions of HRP-labelled secondary antibodies (Sigma). After washing in PBS with 0.1% Tween 20, bound antibody was visualised using enhanced chemiluminescence. 125I-labelled purified mouse monoclonal IgG was produced by the chloramine-T method [10]. This IgG was repurified by gel filtration; only a single iodinated 150 kDa band was present after autoradiography/non-reducing SDS-PAGE.
###end p 11
###begin title 12
BIAcore
###end title 12
###begin p 13
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">[11]</xref>
###xml 252 259 247 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Variola</italic>
###xml 661 662 655 656 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 664 667 658 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#967;</italic>
###xml 667 668 659 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Peptides were amine-coupled to a CM5 chip using standard methods [11]. The four available channels were coupled with a 10 muM solution of either KENIIFGVSYDEYRYRS (wild-type CFTR 503-519, KENIIGVSYDEYRYRS (DeltaF508 CFTR 503-518), GTFIKENIIWKGIYTYRII (Variola I6 P33002 326-344), QRVGLLGRTGSGKSTLL (control NBD2 CFTR 1237-1253) or the final channel was left blank as a baseline control. Analyte was passed over each channel in this order; the signal from the final channel (NBD2 or blank) was automatically subtracted from all other traces. IgG (10-40 muM; Sigma I4506) was used as analyte in proprietory Biacore buffer. Biacore software was used to calculate KD; chi2 values were within prescribed confidence limits.
###end p 13
###begin title 14
Immunofluorescence
###end title 14
###begin p 15
###xml 644 645 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 246 252 <span type="species:ncbi:9793">donkey</span>
###xml 353 358 <span type="species:ncbi:10090">mouse</span>
###xml 524 529 <span type="species:ncbi:10090">mouse</span>
Nasal cells from patients undergoing unrelated surgery (local ethical committee approved) were fixed in 4% paraformaldehyde, incubated in 1 mM glycine for 15 min, permeabilised using 1% Triton X-100, washed three times in PBS, then blocked in 5% donkey serum for 15 min. Cells were incubated in primary antibodies (FITC-labelled anti-hIgG (Jackson) and mouse anti-CFTR NBD1 (Neomarkers, Ab-3) at 1:100) at room temperature, with shaking, overnight. After three washes in PBS, cells were stained with rhodamine-labelled anti-mouse IgG (Jackson, 1:100). After 2 h incubation, with shaking, the cells were washed five times in PBS and mounted (6% n-propyl gallate, 70% glycerol, 100 mM Tris/HCl, pH 7.4). Coverslips were sealed with nail varnish for image capture using a Zeiss 510 laser-scanning confocal microscope.
###end p 15
###begin title 16
Precipitations
###end title 16
###begin p 17
###xml 98 102 98 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr">[12]</xref>
###xml 734 736 721 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 769 773 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr">[13]</xref>
###xml 913 914 899 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 954 956 934 936 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1061 1063 1035 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
Ovine tracheal epithelial membranes were prepared and detergent-extracted as previously described [12]. A centrifuged extract was used for precipitation with protein-G Sepharose beads (Pharmacia), i.e. the sample generated was the equivalent of the normally-discarded 'pre-clearing' step applied in immunoprecipitation protocols to eliminate non-specific, protein-G interactions. Here we required these interactions to be present and used competitive CFTR-peptide incubations to provide specificity. Twenty micrograms of detergent-extracted protein was incubated with 5 mul of protein-G (or A) Sepharose bead slurry +/- peptide, and vortexed overnight at 4 degreesC. The precipitates were washed and phosphorylated with PKA and [gamma32P]-ATP to visualise CFTR protein [13]. One unit of PKA catalytic subunit (Calbiochem-Novabiochem) was incubated with each sample in 50 mul of 50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 100 muM unlabelled ATP, 10 muCi [gamma32P]-ATP (30 degreesC, 30 min) with vortexing. The phosphorylated beads were subjected to SDS-PAGE and the 32P-labelled bands visualised using a Packard InstantImager.
###end p 17
###begin title 18
Results
###end title 18
###begin p 19
###xml 132 138 132 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 105 110 <span type="species:ncbi:10090">mouse</span>
###xml 585 591 <span type="species:ncbi:10090">murine</span>
Tracheal staining using peroxidase-labelled protein G intensely stained the apical membrane of wild-type mouse tracheal epithelium (Fig. 1A, brown colour wild-type left panel, representative of n = 3). Attenuated or absent membrane staining was observed at the apical membrane of two different CFTR mutant tissues (CFTR-null or DeltaF508-CFTR, respectively). Aggregations of protein G staining were observed in the null tissue (red arrows). Since the sole difference between these epithelia was the absence (CFTR-null) or mutation (DeltaF508) of CFTR, these data suggest not only that murine IgG is localised to the apical membrane in wild-type trachea, but also that CFTR mutation can affect expression and localisation of epithelial IgG. We confirmed this differential staining using secondary anti-IgG antibodies alone (not shown).
###end p 19
###begin p 20
###xml 270 276 270 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 677 683 673 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 798 801 794 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 873 879 869 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig. 1</xref>
###xml 55 60 <span type="species:ncbi:9606">human</span>
###xml 781 786 <span type="species:ncbi:10090">mouse</span>
To localise the defect, peptides were synthesised from human CFTR local to F508, amino acids 503-516 in CFTR. These and control peptides from other parts of CFTR or unrelated proteins were each immobilised on nitrocellulose and overlaid with different IgG preparations. Fig. 1B shows binding of purified IgG to immobilised wild-type (KF) peptide (referred to as KENIIF, where F is F508) compared to the equivalent DeltaF508 (KI) sequence (referred to as KENII) and three control peptides. We found that three unrelated peroxidase-labelled anti-IgG antibodies recognising different species all bound specifically to KENIIF, minimally to KENII and did not bind control peptides (Fig. 1B, top three panels). To exclude the possibility that the interaction was with peroxidase, a pure mouse monoclonal 125I-labelled IgG was overlaid and found to bind wild-type KENIIF peptide (Fig. 1B, bottom panel). Thus, in vitro, peptides corresponding to the F508 region of CFTR can bind IgG provided F508 is present.
###end p 20
###begin p 21
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 313 314 313 314 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</sub>
###xml 398 404 398 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 573 580 573 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14 bib15" ref-type="bibr">[14,15]</xref>
###xml 581 581 581 581 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="fx1"/>
###xml 581 581 581 581 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="N0x1cd3410N0x29b83c0"><graphic xlink:href="fx1"/></fig>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 258 263 <span type="species:ncbi:9606">human</span>
To quantify this in vitro interaction we applied human IgG to the BIAcore system, which utilises surface plasmon resonance to validate protein-protein interactions in real time. We immobilised KENIIF, KENII or a control peptide on Biacore chips and perfused human IgG at two different concentrations as analyte. KD was determined to be 69 nM for the KENIIF peptide and 86 nM for the KENII peptide (Fig. 2A). Similarity searches revealed significant homology between the KENIIF region of CFTR and antibody-binding domains of protein L, a bacterial virulence-related protein [14,15].
###end p 21
###begin p 22
Protein L interacts specifically with kappa light chains, whereas the more commonly used antibody-binding proteins (A/G) both bind the heavy chain of IgG.
###end p 22
###begin p 23
###xml 104 110 95 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 921 925 903 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 141 146 <span type="species:ncbi:9606">human</span>
We compared the binding of KENIIF, KENII and protein L to kappa- and lambda-containing isoforms of IgG (Fig. 2B). Identical amounts of total human IgG or three isoforms of IgG were immobilised on 96-well plates and screened for biotinylated peptide binding. Biotinylated KENIIF peptide bound them all with equal efficacy, KENII showed a significantly reduced interaction, whereas IgA bound KENIIF, KENII and protein L with equal efficacy. Protein L bound IgG containing the kappa (but not lambda) light chain as expected. These data confirm that KENIIF peptide can bind IgG and that F508 regulates binding. Further work will have to establish the number of sites where this interaction takes place but judging by our recent experience with the complex interaction of the multimeric protein kinase CK2 with the very same KENIIF region of CFTR, this is likely to involve more than just one motif on the interacting protein [16]. Our working hypothesis is that this region can adopt more than one conformation.
###end p 23
###begin p 24
###xml 184 188 184 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">[17]</xref>
###xml 261 267 261 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 876 882 867 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 148 153 <span type="species:ncbi:9606">human</span>
###xml 199 204 <span type="species:ncbi:9606">human</span>
###xml 231 236 <span type="species:ncbi:9606">human</span>
###xml 460 468 <span type="species:ncbi:9606">patients</span>
Next, we investigated whether IgG localises with CFTR in vivo using immunofluorescence and laser-scanning confocal microscopy. We stained wild-type human ciliated airway cell biopsies [17] with anti-human IgG (FITC-label) and anti-human CFTR (rhodamine-label). Fig. 3A shows that CFTR and IgG staining colocalises specifically at the ciliated apical membrane of wild-type cells. Staining for both proteins was absent in cells from three DeltaF508/DeltaF508 CF patients. To determine whether the F508 region is responsible for the observed colocalisation, we attempted competition with cell-permeant KENIIF/KENII CFTR peptides. KENIIF and KENII peptides were myristoylated (myr-) and the ciliated cells were incubated in the presence of 10 muM peptide for 4 h prior to fixation and staining. Incubation with myr-KENIIF (but not myr-KENII) peptide abolished the colocalisation (Fig. 3B).
###end p 24
###begin p 25
###xml 238 242 238 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr">[18]</xref>
###xml 375 381 375 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 727 733 727 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 206 211 <span type="species:ncbi:9940">sheep</span>
###xml 878 883 <span type="species:ncbi:10090">mouse</span>
###xml 885 890 <span type="species:ncbi:9940">sheep</span>
###xml 895 900 <span type="species:ncbi:9606">human</span>
We theorised that, if CFTR is bound to IgG in vivo, protein-G Sepharose should coprecipitate IgG and CFTR from epithelial membrane extracts without needing an antibody to CFTR. Protein-G precipitation from sheep tracheal membrane extract [18] pulled down a PKA-phosphorylatable band at the molecular weight of CFTR that was not present in an identical protein-A precipitate (Fig. 4A). Since protein G binds ovine IgG, but protein A does not bind as efficiently, the simplest interpretation was that the phosphorylatable band interacted with an endogenous, ovine, membrane-associated IgG. Again, the protein G interaction was inhibitable with KENIIF, but not KENII or another peptide, specifying the interaction to this region (Fig. 4A). These experiments also confirmed that the interaction is with endogenous antibody and not an artefact of the tagged antibodies. Thus, across mouse, sheep and human airway epithelia, the data consistently suggest that CFTR can bind IgG. The similarity between CFTR and protein L suggests that these IgG-binding molecules may have a similar mode of interaction.
###end p 25
###begin p 26
###xml 85 91 85 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 244 250 244 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 252 252 252 252 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="fx2"/>
###xml 252 252 252 252 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="N0x1cd3410N0x29b8480"><graphic xlink:href="fx2"/></fig>
Protein L is not the only molecule having sequence homology with this KENIIF region; Fig. 5 shows that certain pathogenic bacterial proteins also contain related sequences; we noticed a striking similarity in a poxviral protein (I6, below, and Fig. 6).
###end p 26
###begin p 27
###xml 60 67 60 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Variola</italic>
###xml 142 148 142 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 186 193 186 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Variola</italic>
We synthesised the KENIIF-equivalent peptide from poxvirus (Variola I6, P33002 326-342) and tested it for interaction with IgG using BIAcore. Fig. 4B shows that the IgG interaction with Variola I6 peptide was the strongest we had tested.
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
Our studies have produced unexpected results that relate to the pathway between DeltaF508 and the disordered immunity responsible for most CF morbidity. The combined data point to an antibody-binding site in CFTR and suggest that CFTR's F508 status may affect apical localisation of IgG. Our data demonstrate, by several independent methods, an F508-dependent interaction between CFTR and IgG. We have shown that the interaction is direct using BIAcore, and can occur in vivo because IgG both colocalises and coprecipitates with CFTR. Furthermore, the binding can be disrupted by exogenous KENIIF (but not KENII) peptide, strengthening the conclusion that this pathogenic region of CFTR binds IgG.
###end p 29
###begin p 30
###xml 285 299 285 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Staphylococcus</italic>
###xml 595 601 595 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 285 299 <span type="species:ncbi:1280">Staphylococcus</span>
Apically-localised IgG provides a first line of defence against respiratory infections and our data suggest that this immune molecule is missing in most cystic fibrosis. Protein G, which binds IgG, is made by staphylococci to evade the immune response and nearly all CF babies develop Staphylococcus infection immediately after birth for unknown reasons. Mucosal inflammation may be hyperactive in CF to compensate for the missing IgG defence. Such a hyperactive compensation might also be present in heterozygotes giving them an advantage in resistance to epithelial infections. Interestingly, Fig. 5 shows that many infectious organisms contain similar sequences; one has been identified as a virulence factor. A protein kinase (CK2) known to regulate viral life cycles also interacts with NBD1 in an F508-dependent manner [16] and it may be that a complex interaction with multiple regulators of immunity occurs at this site which might relate to the locally restricted types of infections found in CF epithelia.
###end p 30
###begin p 31
###xml 371 375 371 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 381 383 377 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</italic>
###xml 515 519 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr">[19]</xref>
###xml 557 561 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 567 569 555 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</italic>
###xml 975 979 911 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CCR5</italic>
###xml 985 987 917 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</italic>
###xml 1220 1224 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">[20]</xref>
###xml 1542 1546 1458 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr">[21]</xref>
###xml 1700 1706 1616 1622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 90 98 <span type="species:ncbi:10255">smallpox</span>
###xml 349 352 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 435 443 <span type="species:ncbi:10255">smallpox</span>
###xml 796 804 <span type="species:ncbi:10255">smallpox</span>
###xml 938 946 <span type="species:ncbi:10255">smallpox</span>
###xml 1314 1321 <span type="species:ncbi:9606">persons</span>
###xml 1356 1364 <span type="species:ncbi:10255">smallpox</span>
We speculate that the presence of an avid IgG-binding peptide in a virulent pathogen like smallpox suggests that it may have evolved this generic IgG-binding capacity either in order to sequester the epithelial immune mechanism or to harness it in some way to its own advantage. We were led to this speculation by epidemiological studies evaluating HIV-resistance genes (CCR5-Delta32) which are reported to be selectively amplified by smallpox outbreaks on a similar timescale and population frequency to DeltaF508 [19]. These authors write; 'Frequency of [CCR5-Delta32] is estimated em leader approximately10% in European populations. The allele is virtually absent in African, Asian, Middle Eastern, and American Indian populationsem leaderThe geographic distribution em leader also implicates smallpox as the most likely historical source of selection em leader Scandinavian populations em leader were hit particularly hard by intense smallpox epidemics. Frequency of the CCR5-Delta32 variant forms a north-to-south [de]clineem leaderwith greatest prevalence in Scandinavian countries'. The frequency of the DeltaF508 mutation follows an almost identical pattern and thus could be due to the same selective pressures [20]. This raises the possibility that the prevalence of CF is due to the greater survival of persons heterozygous for DeltaF508 during smallpox epidemics, wherein childhood mortality reached 80%. Although the mechanism is unclear, we note that I6 is important in viral replication and viral capsid filling with viral DNA [21]; our observation that I6 can bind IgG additionally relates I6 to the host immune response, possibly using a similar mechanism to the organisms listed in Fig. 5. Further work is needed to establish exactly how this mechanism functions.
###end p 31
###begin p 32
###xml 1217 1221 1213 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 1246 1250 1242 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">[22]</xref>
###xml 1552 1559 <span type="species:ncbi:9606">patient</span>
We do not yet know which sites within IgG bind to the peptides reported here but it is becoming clear that this region of CFTR is on the surface of the nucleotide-binding domain where it is accessible to a number of partners. That F508 appears to be important for this interaction is interesting from a CF perspective. We suggest caution in interpretation of results from CFTR experiments that use antibodies, particularly from native epithelial tissues. For example, pre-clearing immunoprecipitations using protein G alone might discard a population of CFTR molecules of biological importance. Our data also add a potential caveat to trafficking therapies for DeltaF508-CFTR. Such treatments may not restore IgG binding. Two decades after the discovery of CFTR, the mechanism responsible for CF disease remains disputed with some stating that 'CF is an ion channel disease' and others claiming that 'CF is a disorder of immunity involving a restricted set of pathogens'. Our contribution is to highlight that the CFTR peptide sequence straddling the site of the commonest (by far) mutation around F508 bears striking similarities with a range of pathogen proteins. We hope that our studies into the diverse in vitro [16] and more recent in vivo [22] functions manifested by such peptides will fuel the debate on CF pathogenesis. Currently, there are three recognised 'i' factors in CF: ions, inflammation and immunity to which we now add a fourth, immunoglobulin. The latter is missing in most CF and we now need to determine the consequences for the patient.
###end p 32
###begin title 33
Acknowledgements
###end title 33
###begin p 34
We thank Dr. W. Stewart and L. Cuthill for iodinating /purifying the antibodies, Dr. Jenny Woof for reagents and advice and Dr. David Meek for critical reading of the manuscript. Work funded by Wellcome Trust (069150/Z/02/Z), 075237/z/04/z (KJT and DC support respectively).
###end p 34
###begin title 35
References
###end title 35
###begin article-title 36
Innate immune response in CF airway epithelia: hyperinflammatory?
###end article-title 36
###begin article-title 37
Airway epithelial cell inflammatory signalling in cystic fibrosis
###end article-title 37
###begin article-title 38
###xml 66 71 <span type="species:ncbi:9606">human</span>
Impact of the F508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure
###end article-title 38
###begin article-title 39
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Normalization of ion transport in murine cystic fibrosis nasal epithelium using gene transfer
###end article-title 39
###begin article-title 40
Differential localization of the cystic fibrosis transmembrane conductance regulator in normal and cystic fibrosis airway epithelium
###end article-title 40
###begin article-title 41
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Early alterations in airway mucociliary clearance and inflammation of the lamina propria in CF mice
###end article-title 41
###begin article-title 42
###xml 99 104 <span type="species:ncbi:9606">human</span>
Relationship between IkappaBalpha deficiency, NFkappaB activity and interleukin-8 production in CF human airway epithelial cells
###end article-title 42
###begin article-title 43
Intestinal inflammation in cystic fibrosis
###end article-title 43
###begin article-title 44
###xml 126 137 <span type="species:ncbi:3704">horseradish</span>
The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes
###end article-title 44
###begin article-title 45
Comparison of methods for immobilization to carboxymethyl dextran sensor surfaces by analysis of the specific activity of monoclonal antibodies
###end article-title 45
###begin article-title 46
Histidine phosphorylation of annexin I in airway epithelia
###end article-title 46
###begin article-title 47
CAMP-dependent protein kinase-mediated phosphorylation of cystic fibrosis transmembrane conductance regulator residue Ser-753 and its role in channel activation
###end article-title 47
###begin article-title 48
Protein L, a bacterial immunoglobulin-binding protein and possible virulence determinant
###end article-title 48
###begin article-title 49
Structure of peptostreptococcal protein L and identification of a repeated immunoglobulin light chain-binding domain
###end article-title 49
###begin article-title 50
Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis
###end article-title 50
###begin article-title 51
###xml 81 86 <span type="species:ncbi:9606">human</span>
A novel chloride-dependent GTP-utilizing protein kinase in plasma membranes from human respiratory epithelium
###end article-title 51
###begin article-title 52
Nucleoside diphosphate kinase and Cl-sensitive protein phosphorylation in apical membranes from ovine airway epithelium
###end article-title 52
###begin article-title 53
###xml 22 30 <span type="species:ncbi:10255">smallpox</span>
###xml 87 90 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Evaluating plague and smallpox as historical selective pressures for the CCR5-Delta 32 HIV-resistance allele
###end article-title 53
###begin article-title 54
Can a place of origin of the main cystic fibrosis mutations be identified?
###end article-title 54
###begin article-title 55
###xml 24 38 <span type="species:ncbi:10245">vaccinia virus</span>
Genetic analysis of the vaccinia virus I6 telomere-binding protein uncovers a key role in genome encapsidation
###end article-title 55
###begin article-title 56
Small interfering peptide (siP) for in vivo examination of the developing lung interactonome
###end article-title 56
###begin p 57
###xml 246 249 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 259 264 <span type="species:ncbi:9606">human</span>
(A) HRP-labelled Protein-G histochemistry on tracheal sections from wild-type, DeltaF508 or CFTR-null mice. (B) Dotblots of KENIIF (KF), KENII (KI) and control peptides (KE and GE) overlaid with HRP-labelled IgG. Bottom panel; autoradiograph of I125-labelled human IgG binding to KENIIF (KF) but not KENII (KI) or control peptides (GE, KH).
###end p 57
###begin p 58
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
(A) Top, BIAcore traces for binding of human IgG (40 nM, analyte) to immobilised peptides. (A) Bottom, BIAcore traces for binding of human IgG (10 nM, analyte) to immobilised peptides. (B) Data comparing binding of biotinylated KENIIF, KENII and protein L to immobilised isoforms of IgG and IgA.
###end p 58
###begin p 59
###xml 295 296 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 35 40 <span type="species:ncbi:9606">human</span>
(A) Immunofluorescent staining for human IgG (FITC) and CFTR (rhodamine) using either wild-type (left panels) or homozygous DeltaF508 primary ciliated nasal epithelial cells (right panels). Far right panel; no primary antibody control (wild-type). Scale bar, 5 muM. Images are representative of n = 4 experiments. (B) As in A but wild-type cells previously incubated with myristoylated (myr) KENIIF or KENII peptide. Images are representative of results from three different experiments.
###end p 59
###begin p 60
###xml 68 73 <span type="species:ncbi:9940">sheep</span>
###xml 372 377 <span type="species:ncbi:9606">human</span>
(A) Autoradiograph showing precipitations from detergent extract of sheep tracheal membranes. Lanes from left: PG, protein G beads alone; +KF, addition of 10 muM KENIIF; +KI, addition of 10 muM KENII; +GE addition of 10 muM control peptide; NM, no membranes; PKA, PKA alone; ProtA, precipitation with protein A. CFTR and PKA are indicated by arrows. (B) BIAcore trace for human IgG (40 nM, analyte) binding to immobilised I6 peptide compared to KENIIF and KENII.
###end p 60
###begin p 61
Alignment of multiple protein sequences from pathogenic organisms that bear similarity to the F508 region of CFTR.
###end p 61
###begin p 62
Alignment of the KENIIW region of I6 from various poxviruses to illustrate conservation of the CFTR-like sequence.
###end p 62

